Inhibitory protein controls the reversion of protoplasts and L forms of Bacillus subtilis to the walled state.
When the cell wall of Bacillus subtilis is removed by lysozyme and the resultant protoplasts are plated on hypertonic soft agar medium, each protoplast forms an L colony. L bodies from such L colonies again plate as L-colony-forming units (CFU). However, if protoplasts or L bodies are "conditioned" by 1 h of incubation in 0.4% casein hydrolysate medium and then incubated in 25% gelatin medium for 1 h, 60 to 100% of the formerly naked cells give rist to bacillary colonies. The present experiments largely explain the mechanism responsible for the "heritable" persistence of the wall-less state in B. subtilis. It is shown that protoplasts produce a reversion inhibitory factor (RIF) which blocks reversion when the cell concentration exceeds 5 x 105 CFU/ml. This inhibitor is nondialyzable and sensitive to trypsin, heat, and detergent. Efficient reversion at 2 x 107 CFU/ml is obtained if the protoplasts are treated with trypsin after conditioning and chloramphenicol is incorporated into the gelatin reversion medium. In the presence of 500 mug of trypsin per ml, the requirement for gelatin is sharply reduced, and reversion occurs rapidly in liquid medium containing only 10% gelatin. Trypsin also stimulates reversion in L colonies growing on soft agar. Latent RIF is activated by beta-mercaptoethanol. This reagent blocks reversion of protoplast suspensions at densities of 5 x 105 CFU/ml. Comparison of the autolytic behavior of B. subtilis and of the RIF revealed that several or the properties of the two activities coincide: both are inhibited by high concentrations of gelatin, both are activated by beta-mercaptoethanol, and both have high affinity for cell wall. Going on the assumption that RIF is autolysin, models for protoplast reversion is suggested by the finding that mutants with altered teichoic acid show altered reversion behavior.
D001412:Bacillus subtilis / Q000254:growth & development* / Q000378:metabolism; D001426:Bacterial Proteins; D002701:Chloramphenicol / Q000494:pharmacology; D005780:Gelatin / Q000378:metabolism; D007740:L Forms / Q000254:growth & development* / Q000378:metabolism; D008623:Mercaptoethanol / Q000494:pharmacology; D011523:Protoplasts / Q000378:metabolism / Q000502:physiology*; D014357:Trypsin / Q000494:pharmacology
D001426:Bacterial Proteins; D008623:Mercaptoethanol; D002701:Chloramphenicol; D005780:Gelatin; D014357:Trypsin